Coronary Artery Bypass at a Drug-Eluting Resorbable Magnesium Scaffold Site in a Porcine Model.
Cohen JE, Garcia-Garcia HM, Hellinga D, Kolodgie F, Virmani R, Finn A, Waksman R.
Cardiovasc Revasc Med. 2022 Sep;42:109-113. doi: 10.1016/j.carrev.2022.02.026. Epub 2022 Feb 28.
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany.
Stachon P, Kaier K, Hehn P, Peikert A, Wolf D, Oettinger V, Staudacher D, Duerschmied D, Zirlik A, Zehender M, Bode C, von Zur Mühlen C.
Clin Res Cardiol. 2022 Jul;111(7):742-749. doi: 10.1007/s00392-021-01931-x. Epub 2021 Aug 28.
Coronary artery bypass grafting or percutaneous revascularization in acute myocardial infarction?
Perrier S, Kindo M, Gerelli S, Mazzucotelli JP.
Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):1015-9. doi: 10.1093/icvts/ivt381. Epub 2013 Aug 20.
Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis.
Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y.
Ren Fail. 2020 Nov;42(1):107-112. doi: 10.1080/0886022X.2019.1710187.
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
Li Y, Hou X, Liu T, Xu S, Huang Z, Xu X, Dong R.
Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022.
A comparison of drug-eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure.
Wang K, Wang L, Cong H, Zhang J, Hu Y, Zhang Y, Zhang R, Li W, Qi W.
ESC Heart Fail. 2022 Jun;9(3):1749-1755. doi: 10.1002/ehf2.13852. Epub 2022 Feb 22.
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.
Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, Virmani R.
Nat Rev Cardiol. 2016 Feb;13(2):79-98. doi: 10.1038/nrcardio.2015.164. Epub 2015 Oct 27.
Management of Restenosis after Stenting in Left Main Coronary Artery Disease.
Huang CW, Huang MS, Su PF, Chao TH, Lee CH, Liu PY.
Acta Cardiol Sin. 2023 Mar;39(2):277-286. doi: 10.6515/ACS.202303_39(2).20220821A.
Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
Xu JJ, Gao Z, Zhang Y, Gao LJ, Chen J, Qiao SB, Gao RL, Yang YJ, Xu B, Yuan JQ.
Catheter Cardiovasc Interv. 2018 Feb 15;91(S1):566-572. doi: 10.1002/ccd.27500. Epub 2018 Jan 23.
